AAX Biotech and Vascurie announce new neuro-oncology collaboration
The collaboration will help to advance a pipeline of antibody candidates
Read More
Author: Esme Needham
Ipsen announces new data on Dysport in neurological disease
Dysport reduces muscle contractions by blocking the transmission of nerve impulses
Read More
Jurgen Berendsen
Symeres has appointed Jurgen Berendsen as Chief Financial Officer (CFO).
Read More
MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
Read More
Matthias Schäfer
Topadur has appointed Matthias Schäfer as CEO
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
